Iovance Biotherapeutics earnings were -$410.0M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest IOVA earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$83.5M, down 14% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, IOVA reported annual earnings of -$444.0M, with 12.2% growth. The next IOVA earnings date is Feb 26, 2025.
Iovance Biotherapeutics Earnings Reports & History FAQ
What were Iovance Biotherapeutics's earnings last quarter?
On IOVA's earnings call on Invalid Date, Iovance Biotherapeutics (NASDAQ: IOVA) reported Q3 2024 earnings per share (EPS) of -$0.28, up 39.13% year over year. Total IOVA earnings for the quarter were -$83.54 million. In the same quarter last year, Iovance Biotherapeutics's earnings per share (EPS) was -$0.46.
When does Iovance Biotherapeutics report earnings?
The next IOVA earnings call is Invalid Date. Add IOVA to your watchlist to be reminded of Iovance Biotherapeutics's next earnings date.
What was IOVA's earnings growth in the past year?
As of Iovance Biotherapeutics's earnings date in Invalid Date, Iovance Biotherapeutics's earnings has grown year over year. IOVA earnings in the past year totalled -$410.00 million.
Is Iovance Biotherapeutics profitable or losing money?
As of the last Iovance Biotherapeutics earnings report, Iovance Biotherapeutics is currently losing money. Iovance Biotherapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$410.00 million, a 5.31% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.